While these findings provide preliminary evidence of the potential benefit of semaglutide in CUD in real-world populations, further preclinical studies are warranted to understand the underlying mechanism and randomized clinical trials are needed to support its use clinically for CUD
[ Read More ] [QUOTE="pswotton, post: 460760, member: 23383"] Thanks for your response
This research shows that even very similar drugs can have slight differences in their actions, which could be important for how they affect the body
Previously, we identified a systemic dose of the GLP-1R agonist exendin-4 that selectively attenuated the reinstatement of cocaine-seeking behavior in rats ( 9 ), an animal model of drug relapse
Host serine proteases: a potential targeted therapy for COVID-19 and influenza
How GLP-1 Therapy Works GLP-1 medications work on the hormone pathways that control appetite and blood sugar